BRAF and cutaneous melanoma: However, BRAF V600 mutations, the most frequent and therapeutically best-targetable gene alteration in cutaneous melanoma (present in ~50% of cases) is only rarely found in mucosal melanomas (≤ 10% of cases), which limits clinical treatment options [6–8].